Thermo Fisher Scientific Inc. (NYSE: TMO)’s stock price has increased by 2.58 compared to its previous closing price of 469.03. However, the company has seen a 4.77% increase in its stock price over the last five trading sessions. Proactive Investors reported 2023-11-14 that Thermo Fisher Scientific (NYSE:TMO) Inc has announced a new $4 billion stock repurchase program, which represents about 2.3% of its market capitalization of $171.99 billion as of Monday’s close.  The analytics, diagnostics and laboratory services company said the new buyback program, which has no expiration date, replaces the existing program that had $1 billion in repurchase authorization remaining.

Is It Worth Investing in Thermo Fisher Scientific Inc. (NYSE: TMO) Right Now?

Thermo Fisher Scientific Inc. (NYSE: TMO) has a price-to-earnings ratio that is above its average at 31.53x. and a 36-month beta value of 0.80. Opinions on the stock are mixed, with 16 analysts rating it as a “buy,” 5 as “overweight,” 6 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price predicted for Thermo Fisher Scientific Inc. (TMO) by analysts is $516.73, which is $35.58 above the current market price. The public float for TMO is 385.73M, and at present, short sellers hold a 0.71% of that float. On November 21, 2023, the average trading volume of TMO was 1.73M shares.

TMO’s Market Performance

The stock of Thermo Fisher Scientific Inc. (TMO) has seen a 4.77% increase in the past week, with a 4.19% rise in the past month, and a -11.75% fall in the past quarter. The volatility ratio for the week is 1.75%, and the volatility levels for the past 30 days are at 2.52% for TMO. The simple moving average for the past 20 days is 6.57% for TMO’s stock, with a -8.84% simple moving average for the past 200 days.

TMO Trading at 0.64% from the 50-Day Moving Average

After a stumble in the market that brought TMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.10% of loss for the given period.

Volatility was left at 2.52%, however, over the last 30 days, the volatility rate increased by 1.75%, as shares surge +4.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.01% lower at present.

During the last 5 trading sessions, TMO rose by +4.57%, which changed the moving average for the period of 200-days by -16.64% in comparison to the 20-day moving average, which settled at $452.57. In addition, Thermo Fisher Scientific Inc. saw -12.63% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TMO starting from CASPER MARC N, who sale 1,600 shares at the price of $460.25 back on Nov 07. After this action, CASPER MARC N now owns 131,175 shares of Thermo Fisher Scientific Inc., valued at $736,404 using the latest closing price.

CASPER MARC N, the Chairman & CEO of Thermo Fisher Scientific Inc., sale 10,000 shares at $454.41 during a trade that took place back on Nov 06, which means that CASPER MARC N is holding 131,175 shares at $4,544,053 based on the most recent closing price.

Stock Fundamentals for TMO

Current profitability levels for the company are sitting at:

The net margin for Thermo Fisher Scientific Inc. stands at +15.47. The total capital return value is set at 10.82, while invested capital returns managed to touch 9.36. Equity return is now at value 13.37, with 6.33 for asset returns.

Based on Thermo Fisher Scientific Inc. (TMO), the company’s capital structure generated 82.03 points at debt to equity in total, while total debt to capital is 45.06. Total debt to assets is 37.13, with long-term debt to equity ratio resting at 68.72. Finally, the long-term debt to capital ratio is 37.75.

When we switch over and look at the enterprise to sales, we see a ratio of 4.78, with the company’s debt to enterprise value settled at 0.15. The receivables turnover for the company is 4.89 and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.48.


To sum up, Thermo Fisher Scientific Inc. (TMO) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.